- Investing Ideas
- /
- Swiss Potentially Undervalued Companies
Swiss Potentially Undervalued Companies
UPDATED May 05, 2024
Companies with a Value score of at least 3, ordered by Value score
363 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SEAN | CHF2.99 | 0% | -6.3% | CHF13.6m | CHF7.75 | PE4x | E19.7% | n/a | Real Estate Management and Development | ||
REP | €14.54 | 0% | n/a | €17.5b | €17.78 | PE5.9x | E-0.9% | 7.0% | Energy | ||
KLIN | CHF17.00 | -4.0% | -12.8% | CHF150.3m | CHF24.51 | PE6.6x | E0.2% | 2.3% | Capital Goods | ||
ZEHN | CHF55.60 | 1.1% | -25.4% | CHF620.1m | CHF67.04 | PE14.7x | E6.0% | 2.3% | Capital Goods | ||
2HQ | US$46.28 | 0% | 0% | US$1.7b | US$52.33 | PS2.3x | E86.1% | n/a | Pharmaceuticals & Biotech | ||
KOMN | CHF161.20 | 0.6% | -33.8% | CHF824.9m | CHF194.52 | PE18.8x | E13.9% | 1.9% | Capital Goods | ||
MT | €29.19 | 0% | 0% | €19.9b | €38.49 | PE28.2x | E41.8% | 1.9% | Materials | ||
SOONE | CHF228.60 | 0% | 0% | CHF15.7b | CHF235.45 | PE26.1x | E10.7% | 1.7% | Healthcare | ||
DBK | €9.80 | 0% | 0% | €30.1b | €11.04 | PE6.8x | E10.3% | 2.9% | Diversified Financials | ||
B5A | €26.60 | 0% | 0% | €232.4m | n/a | PB0.5x | S3.0% | n/a | Capital Goods | ||
LMT | US$430.00 | 0% | 0% | US$110.8b | US$453.49 | PE16.4x | E0.9% | 2.7% | Capital Goods | ||
NOVNEE | CHF88.25 | -1.3% | -6.0% | CHF179.5b | CHF98.47 | PE21.8x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
MTG | CHF31.00 | -0.2% | -43.3% | CHF349.9m | CHF45.00 | PE12.9x | E9.9% | 4.2% | Capital Goods | ||
RDN | €54.72 | 0% | 0% | €8.3b | €57.34 | PE15.1x | E13.1% | 4.9% | Commercial Services | ||
NOKIA | €4.90 | 0% | 0% | €18.9b | €5.63 | PE23.2x | E16.2% | 3.8% | Tech | ||
PMN | CHF494.00 | 1.0% | 17.3% | CHF471.8m | CHF464.39 | PE10.7x | E-3.1% | 6.0% | Capital Goods | ||
SCR | €29.82 | 0% | 28.1% | €5.3b | €34.83 | PE6.6x | E4.3% | 6.0% | Insurance | ||
VRX | US$24.11 | 0% | 0% | US$2.9b | US$31.49 | PE-6.3x | E95.1% | n/a | Pharmaceuticals & Biotech | ||
ABX | CA$21.00 | 0% | 0% | CA$39.5b | CA$27.22 | PE20x | E16.1% | 2.4% | Materials | ||
CLTN | CHF52.80 | 1.1% | -27.1% | CHF315.5m | CHF62.00 | PE26.4x | E20.9% | 3.8% | Healthcare | ||
CS | €27.90 | 0% | -26.7% | €69.1b | €33.45 | PE9.9x | E5.9% | 6.3% | Insurance | ||
HOCN | CHF9.72 | 594.3% | -51.2% | CHF20.9m | CHF11.00 | PB0.1x | E103.0% | 0% | Food, Beverage & Tobacco | ||
AERO | CHF18.14 | 1.9% | 13.9% | CHF1.1b | CHF21.84 | PB1.2x | E78.8% | n/a | Capital Goods | ||
EBAY | US$38.34 | 0% | 0% | US$25.1b | US$40.10 | PE9.5x | E-6.6% | 2.2% | Retail |